Legal Opinion
United States v. Regenerative Sciences, LLC
District Court, District of Columbia
Decided July 23, 2012No. Civil Action No. 2010-1327PublishedCited by 6 opinions
1Opinion of the Court
MEMORANDUM OPINION
ROSEMARY M. COLLYER, District Judge.
Drs. Christopher J. Centeno and John R. Schultz developed the Regenexx™ Procedure, by which they use stem cell therapies to aid healing for their orthopedic patients. They formed Regenerative Sciences LLC (“Regenerative”) for this endeavor, at which Michelle R. Cheever is the Laboratory Director. They are all now facing an enforcement action by the Food and Drug Administration (“FDA”), which charges them with “causing articles of drug to become adulterated” and “misbranded” within the meaning of the Federal Food, Drug, and Cosmetic Act…
2Cases cited36 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Bennett v. SpearSupreme Court of the United States · 1997
31 more not listed; retrieve them via the Exa API.
3Cited by6 opinions
- Slate v. Public Defender Service for the District of ColumbiaDistrict Court, District of Columbia · 2014
- United States v. Regenerative Sciences, LLCCourt of Appeals for the D.C. Circuit · 2014
- McAfee v. U.S. Food and Drug AdministrationDistrict Court, District of Columbia · 2021
- Osullivan, M.D. v. U.S. Department of Health and Human ServicesDistrict Court, District of Columbia · 2024
- Prevor v. United States Food & Drug AdministrationDistrict Court, District of Columbia · 2014
1 more not listed; retrieve them via the Exa API.